Vericiguat in patients with atrial fibrilation and heart failure with reduced ejection fraction: insights from the VICTORIA (VerICiguaT global study in subjects with HFrEF)

30 June 2021 (16:28 - 16:45)
Organised by:
Congress Presentation Part of: Late-Breaking Trials 2 Pharmacotherapy HFA Premium Access Heart Failure 2021

ESC 365 is supported by

ESC 365 is supported by